Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cesium ion (Cs⁺) is the monovalent cation of cesium. It is not a typical therapeutic target but can be relevant in toxicology, particularly in cases of radiation exposure involving radioactive cesium isotopes. Cs⁺ can interfere with normal biological processes, especially those involving potassium ions (K⁺), due to its similar charge and ionic radius, though larger size. Prussian blue is used as a chelating agent to remove cesium from the body.
Prussian blue binds to cesium ions in the gastrointestinal tract, preventing their absorption and promoting their excretion in feces.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cesium Ion (Cs⁺).